全球MRI造影劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計 MRI造影劑市場將從 2025 年的 30.7 億美元成長到 2034 年的 58.9 億美元，2026 年至 2034 年的複合年成長率為 7.49%。

隨著全球對先進診斷影像技術的需求不斷成長，全球造影造影（MRI）造影劑市場正穩步發展。 MRI造影劑能夠提高影像清晰度和準確性，有助於檢測和後續觀察包括癌症和神經系統疾病在內的多種疾病。慢性病發病率的上升和診斷影像檢查的普及是推動市場成長的主要因素。 MRI系統的技術進步也進一步刺激了對高效能造影劑的需求。

關鍵成長要素包括擴大醫療保健服務覆蓋範圍和提升新興經濟體的診斷能力。更安全、更有效率且副作用更小的造影劑的研發，增強了病人和醫生的信心。新配方獲得監管部門核准以及對非钆替代品的持續研究，正在塑造創新趨勢。此外，人們健康意識的提高和預防性篩檢工作的發展，也促進了影像檢查的成長。

展望未來，持續進行旨在提升安全性和性能的研發活動預計將惠及市場。個人化成像方法和分子成像技術的進步將創造新的機會。隨著醫療機構更加重視疾病的早期檢測和精準診斷，全球MRI造影劑市場預計將保持穩定成長。製藥公司和影像公司之間合作的加強有望推動進一步的創新。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球MRI造影劑市場：依產品分類

• 市場分析、洞察與預測
• 順磁性造影劑
• 超順造影劑

第5章 全球MRI造影劑市場：依類型分類

• 市場分析、洞察與預測
• 臨床
• 臨床前

第6章 全球MRI造影劑市場：依應用領域分類

• 市場分析、洞察與預測
• 消化器官系統
• 靜脈
• 肝膽系統
• 神經影像學
• 其他

第7章：全球MRI造影劑市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診斷影像中心

第8章 全球MRI造影劑市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • GE Healthcare
  • Bayer AG
  • Guerbet GmbH
  • Bracco Imaging SPA
  • Vitalquan LLC
  • Miltenyi Biotec BV & Co. KG
  • Lantheus Medical Imaging Inc
  • NanoPET Pharma GmbH
  • Jodas Expoim Pvt Ltd
  • Zhejiang Hisun Pharmaceutical Co. Ltd

The MRI Contrast Media Agents Market size is expected to reach USD 5.89 Billion in 2034 from USD 3.07 Billion (2025) growing at a CAGR of 7.49% during 2026-2034.

The Global MRI Contrast Media Agents Market is growing steadily as demand for advanced diagnostic imaging rises worldwide. MRI contrast agents enhance image clarity and accuracy, aiding in the detection and monitoring of various diseases, including cancer and neurological disorders. Increasing prevalence of chronic illnesses and the growing number of diagnostic imaging procedures are driving market growth. Technological advancements in MRI systems further support the need for effective contrast agents.

Key growth drivers include expanding healthcare access and improved diagnostic capabilities in emerging economies. The development of safer, more efficient contrast agents with reduced side effects has strengthened patient and physician confidence. Regulatory approvals for new formulations and continuous research into non-gadolinium-based alternatives are shaping innovation trends. Additionally, rising healthcare awareness and preventive screening initiatives contribute to increased imaging volumes.

Looking ahead, the market is expected to benefit from ongoing R&D activities aimed at enhancing safety and performance. Personalized imaging approaches and advancements in molecular imaging will create new opportunities. As healthcare providers focus on early disease detection and precision diagnostics, the Global MRI Contrast Media Agents Market is projected to maintain stable growth. Increasing collaborations between pharmaceutical and imaging companies will further drive innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Paramagnetic Agents
• Superparamagnetic Agents

By Type

• Clinical
• Preclinical

By Application

• Gastrointestinal
• Intravenous
• Hepatobiliary
• Neurological Imaging
• Others

By End-use

• Hospitals
• Imaging Centers

COMPANIES PROFILED

• GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging SpA, Vitalquan LLC, Miltenyi Biotec BV Co KG, Lantheus Medical Imaging Inc, nanoPET Pharma GmbH, Jodas Expoim Pvt Ltd, Zhejiang Hisun Pharmaceutical Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Paramagnetic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Superparamagnetic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Preclinical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Gastrointestinal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hepatobiliary Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Neurological Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MRI CONTRAST MEDIA AGENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 GE Healthcare
  • 10.2.2 Bayer AG
  • 10.2.3 Guerbet GmbH
  • 10.2.4 Bracco Imaging S.P.A
  • 10.2.5 Vitalquan LLC
  • 10.2.6 Miltenyi Biotec B.V. & Co. KG
  • 10.2.7 Lantheus Medical Imaging Inc
  • 10.2.8 NanoPET Pharma GmbH
  • 10.2.9 Jodas Expoim Pvt Ltd
  • 10.2.10 Zhejiang Hisun Pharmaceutical Co. Ltd